Skip to main content
. Author manuscript; available in PMC: 2013 Dec 1.
Published in final edited form as: Cancer Res. 2013 May 10;73(11):3316–3325. doi: 10.1158/0008-5472.CAN-12-3015

Figure 3.

Figure 3

Binding of LD22-4 to U87MG cells. Competition binding studies were performed with 2.5 μM biotinylated-LD22-4 in the absence (A) or presence of 20-fold (B) or 60-fold (C) unlabeled LD22-4. Fluorescence images are shown in the upper panels and transmission images are shown in the bottom panels. In separate experiments, binding studies were performed with 2.5 μM biotinylated-LD22-4 (D) or biotinylated-LD63-6 (E). Magnification: 100X.